首页 > 市场调查报告书 > 製药

骨疾病

北美骨关节炎治疗市场预测至 2030 年 - 区域分析 - 按治疗类型、疾病适应症和最终用户

市场调查报告书

商品编码

1562203

北美骨关节炎治疗市场预测至 2030 年 - 区域分析 - 按治疗类型、疾病适应症和最终用户

North America Osteoarthritis Therapy Market Forecast to 2030 - Regional Analysis - by Therapy Type, Disease Indication, and End User

出版日期: 2024年07月04日 | 出版商:

The Insight Partners | 英文 107 Pages | 订单完成后即时交付

价格

简介目录图表

2022年北美骨关节炎治疗市值为78.7388亿美元，预计2030年将达到135.798亿美元；预计2022年至2030年复合年增长率为7.1%。

更有效的治疗方案推动北美骨关节炎治疗市场

目前，OA 尚无治癒方法。一组临床研究科学家透过临床试验表明，他们正在开发可以阻止 OA 进展的创新治疗目标选择。例如，2021年11月，LG化学公司宣布启动下一代治疗关节炎新药的临床试验。此外，2021年10月，Pacira BioSciences, Inc.宣布收购 Flexion Therapeutics，以治疗非鸦片类疼痛管理药物「ZILRETTA」。该药物于 2017 年获得批准，是第一个也是唯一一个获得批准的利用缓释微球技术治疗 OA 膝关节疼痛的药物。

2023年9月，Sorrento Therapeutics, Inc.宣布「树脂毒素（RTX）计画」的2期顶线临床试验结果正面。这项 2 期试验是一项多中心、双盲、安慰剂和主动对照研究，评估 RTX 多个剂量组治疗中重度 OAK 患者疼痛的有效性和安全性。此外，Sorrento 决定将一种已批准的竞争药物「Zilretta」纳入目前的临床试验方案中。

北美骨关节炎治疗市场概况

北美骨关节炎治疗市场分为美国、加拿大和墨西哥。美国食品药物管理局（FDA）针对骨关节炎药物的快速产品上市以及政府对加速产品上市的支持是市场成长的最大影响因素。根据美国疾病管制与预防中心 (CDC) 报告中揭露的统计数据，骨关节炎 (OA) 是最常见的关节炎形式，影响 3,250 万美国成年人。此外，骨关节炎 (OA) 行动联盟报告显示，美国每年与 OA 相关的总体经济负担估计为 1,368 亿美元。此外，美国伦琴射线协会 ARRS 报告显示，终生罹患 OA 的风险为 50%，预计到 2040 年，约 7,800 万（26%）美国成年人将患有 OA。

此外，製造商批准的针对骨关节炎疼痛非药物疗法的新产品进一步影响了市场成长。例如，2021 年 6 月，CyMedica Orthopaedics 宣布其「Intellihab 系统」获得美国食品和药物管理局 (USFDA) 的批准，这是一种治疗膝骨关节炎疼痛的非侵入性疗法。此次推出的新产品是一个基于数字的治疗生态系统，旨在治疗骨关节炎疼痛和衰弱性骨关节炎疾病。因此，针对骨关节炎疼痛的新型非药物疗法，重点在于减少对治疗的依赖，是推动骨关节炎治疗市场成长的关键因素。

北美骨关节炎治疗市场收入及 2030 年预测（百万美元）

北美骨关节炎治疗市场区隔

北美骨关节炎治疗市场按治疗类型、疾病适应症、最终用户和国家分类。

依治疗类型，北美骨关节炎治疗市场分为经皮神经电刺激（TENS）、职能治疗、物理治疗、富血小板血浆（PRP）治疗及基质血管成分、增生疗法等。 2022 年，物理治疗领域占据最大的市场。

从疾病适应症来看，北美骨关节炎治疗市场细分为膝骨关节炎、脊椎骨关节炎、足踝骨关节炎、肩骨关节炎、手骨关节炎等。 2022 年，膝骨关节炎细分市场占据北美骨关节炎治疗市场的最大份额。

根据最终用户，北美骨关节炎治疗市场分为医院和诊所、专科诊所、门诊手术中心、家庭护理等。 2022 年，家庭护理领域占据北美骨关节炎治疗市场的最大份额。

依国家/地区划分，北美骨关节炎治疗市场分为美国、加拿大和墨西哥。 2022 年，美国在北美骨关节炎治疗市场占有率中占据主导地位。

Vision Quest Industries Inc、Dr PRP USA LLC、Zimmer Biomet Holdings Inc、DePuy Synthes Inc、Bioventus Inc、Omron Healthcare Inc、Exactech Inc 和 Medi GmbH & Co KG 是北美骨关节炎治疗市场上的一些领先公司。

Currently, there is no cure for OA. A group of clinical research scientists, through clinical trials, reveal that they are developing innovative treatment target options that can stop the progression of OA. For example, in November 2021, LG Chem company announced the initiation of a clinical trial for next-generation new drugs to treat arthritis. Additionally, in October 2021, Pacira BioSciences, Inc. announced the acquisition of Flexion Therapeutics to treat non-opioid pain management "ZILRETTA". The drug approved in 2017 is the first and only approved treatment for OA knee pain utilizing extended-release microsphere technology.

In September 2023, Sorrento Therapeutics, Inc. announced positive Phase 2 top-line clinical trial results for the "Resiniferatoxin (RTX) program". The Phase 2 trial is a multi-center, double-blind, placebo, and active-controlled study assessing the efficacy and safety of several dose groups of RTX to manage pain in patients with moderate-to-severe OAK. Also, Sorrento decided to include an active approved competitor drug, "Zilretta," in the current clinical trial protocol.

North America Osteoarthritis Therapy Market Overview

North America osteoarthritis therapy market is segmented as US, Canada, and Mexico. Fast product launches by the US Food and Drug Administration (FDA) for osteoarthritis drugs and government support for accelerating product launches are the most impacting factors for the market growth. According to the statistics revealed in the Centers for Disease Control and Prevention (CDC) report, osteoarthritis (OA) is the most common form of arthritis, affecting 32.5 million US adults. Additionally, the Osteoarthritis (OA) Action Alliance report reveals that the overall economic burden associated with OA in the US is estimated at US$ 136.8 billion annually. Further, the American Roentgen Ray Society ARRS report reveals that the lifetime risk of OA is 50%, and it is estimated that by 2040, ~78 million (26%) US adults will have OA.

Further, new product approvals by the manufacturers aiming for non-pharmacology therapy for OA pain further influence market growth. For instance, in June 2021, CyMedica Orthopedics announced receiving approval for the "Intellihab System," a noninvasive modality for knee osteoarthritis pain by the US Food and Drug Administration (USFDA). The new product launch is a therapeutic and digital-based ecosystem that is designed to treat OA pain with a debilitating osteoarthritis disease. Therefore, new non-pharmacology therapy intended for OA pain focusing on reducing dependency on therapeutics is a key factor for fueling the growth of the osteoarthritis therapy market.

North America Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)

North America Osteoarthritis Therapy Market Segmentation

The North America osteoarthritis therapy market is categorized into therapy type, disease indications, end user, and country.

Based on therapy type, the North America osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share in 2022.

In terms of disease indications, the North America osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held the largest share of North America osteoarthritis therapy market in 2022.

Based on end user, the North America osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held the largest share of North America osteoarthritis therapy market in 2022.

By country, the North America osteoarthritis therapy market is segmented into the US, Canada, and Mexico. The US dominated the North America osteoarthritis therapy market share in 2022.

Vision Quest Industries Inc, Dr PRP USA LLC, Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc, and Medi GmbH & Co KG are some of the leading companies operating in the North America osteoarthritis therapy market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

4.1 Pipeline Analysis
- 4.1.1 Clinical Trial Pipeline Analysis

5. North America Osteoarthritis Therapy Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Osteoarthritis
- 5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
- 5.2.1 Product Recall
5.3 Market Opportunities
- 5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
- 5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - North America Market Analysis

6.1 Overview
- 6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

7. North America Osteoarthritis Therapy Market Analysis - by Therapy Type

7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
- 7.2.1 Overview
- 7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
- 7.3.1 Overview
- 7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
- 7.4.1 Overview
- 7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
- 7.5.1 Overview
- 7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
- 7.6.1 Overview
- 7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Osteoarthritis Therapy Market Analysis - by Disease Indication

8.1 Overview
8.2 Knee Osteoarthritis
- 8.2.1 Overview
- 8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
- 8.3.1 Overview
- 8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
- 8.4.1 Overview
- 8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
- 8.5.1 Overview
- 8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
- 8.6.1 Overview
- 8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Osteoarthritis Therapy Market Analysis - by End User

9.1 Overview
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
- 9.3.1 Overview
- 9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
- 9.5.1 Overview
- 9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Osteoarthritis Therapy Market - Country Analysis

10.1 North America Market Overview
- 10.1.1 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 United States: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.1.4 United States: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.1.5 United States: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Canada: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.2.4 Canada: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.2.5 Canada: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.3 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 Mexico: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.3.4 Mexico: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.3.5 Mexico: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 Vision Quest Industries Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Dr PRP USA LLC
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Zimmer Biomet Holdings Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 DePuy Synthes Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Bioventus Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Omron Healthcare Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Exactech Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Medi GmbH & Co KG
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments

13. Appendix

13.1 About the Insight Partners

简介目录图表

List Of Tables

Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Organic Developments Done by Companies
Table 13. Inorganic Developments Done by Companies

List Of Figures

Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. North America: Osteoarthritis Therapy Market by Key Countries - Revenue (2022) US$ Million
Figure 26. North America: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Growth Strategies in the Osteoarthritis Therapy market